Jiutian Chemical (SGX:C8R) reported a full-year loss of 147.9 million yuan for fiscal year 2024, 97,000 yuan more than previously stated, after audit adjustments, according to a Monday filing on the Singapore Exchange.
Revenue was restated to 50.6 million yuan from 243.8 million yuan after reclassifying certain trades as agency transactions. Cost of sales dropped in line, leaving gross profit unchanged.
Finance costs rose to 6.1 million yuan after correcting the capitalization of borrowing costs. Other changes included asset reclassifications, tax provisions, and the reversal of excess impairment losses.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。